Joshua Proehl

Human APOBEC3B promotes tumor heterogeneity in vivo including signature mutations and metastases

R. Sotillo, R. Vogel, H. Nilsen, 2023, bioRxiv.

DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo

D. Largaespada, M. Carpenter, W. Brown, 2023, International journal of molecular sciences.

Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases

R. Sotillo, Rena Levin-Klein, L. Alsøe, 2023, Cell reports. Medicine.